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ABSTRACT
Objectives: Keloid occurred due to abnormal wound healing, characterized by massive fibroblast proliferation and excessive collagen accumulation. 
Tithonia diversifolia Hemsley A. Gray has been known to show antiproliferative effect against some cancer cells in vitro. However, its potential as anti-
keloid has not been explored. This study aims to assess the T. diversifolia ethanolic extract effect on fibroblast migration activity, transforming growth 
factor-beta1 (TGF-β1), and vascular endothelial growth factor (VEGF) expression of keloid fibroblasts in vitro.
Methods: Fibroblasts were isolated from keloid collected from patient keloid tissue. The migration activity of keloid fibroblasts was assessed using 
scratch assay. The TGF-β1 and VEGF expression examination was done using ELISA.
Results: Ethanolic extract of T. diversifolia treatment at a concentration of 20 µg/ml, 10 µg/ml, and 5 µg/mL for 24 h on keloid fibroblasts culture 
showed slower migration activity compare to those on keloid fibroblast culture without treatment (p<0.05). The TGF-β1 and VEGF expression was 
significantly lower in ethanolic extract of T. diversifolia treatment group compared to those on keloid fibroblast without treatment (p<0.05).
Conclusion: Ethanolic extract of T. diversifolia inhibits fibroblast migration activity and decrease the expression of VEGF and TGF-β1 on keloid 
fibroblasts in vitro.
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INTRODUCTION
Keloid is a fibroproliferation dermal tumor, harmless, that grew in 
the scar and exceeds the wound limit. In developing countries, there 
are around 100 million patients who have scarring complaints. Those 
are giving the impact on physical condition, esthetic, psychological, 
and social [1,2]. Keloid is characterized by excessive accumulation of 
extracellular matrix components such as collagen, fibronectin, elastin, 
proteoglycans and growth factors [3].
Keloid therapy actually has been widely practiced with a variety of 
side effects that have been reported as long-term therapy with an 
injection of triamcinolone acetonide and mitomycin C can cause skin 
atrophy, telangiectasia, and pigmentation disorders [4]. Some studies 
about keloid have been done, but research on the natural product is 
still very few. One of the natural ingredients that have been studied is 
the Tithonia diversifolia (Hemsley) A. Gray. Initial studies on keloids 
suggested that the standardized ethanol extract of T. diversifolia 
can inhibit keloid fibroblast proliferation and collagen deposit [5]. 
The active compound of T. diversifolia shows cytotoxicity against 
cancer cells, is Tagitinin C which is a sesquiterpene lactones class, 
and was isolated from the leaves of T. diversifolia (Hemsley) A. Gray 
using a bioassay-guided isolation method ((3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide [MTT] on cells HeLa 
IC50: 9.776 µg/mL) [6]. Tagitinin C proved able to inhibit collagen 
accumulation on keloid fibroblasts in vitro [7]. Therefore, research on 
ethanolic extract of T. diversifolia (Hemsley) A. Gray against migration 
activity and expression of transforming growth factor-beta1 (TGF-β1) 
and vascular endothelial growth factor (VEGF) in fibroblast Keloids 
needs to be studied.
MATERIALS AND METHODS
Keloid fibroblasts used were a subculture passage III-IV, obtained 
from the laboratory of health technology, Dermatology Venereology 
Division, Faculty of Medicine Gadjah Mada University. Materials used 
were T. diversifolia (Hemsley) A. Gray leaves collected from Pakem-
Yogyakarta special district of Indonesia on February 2017, identified 
at the laboratory plant systematics, and voucher specimen no: 0579/S.
Tb./IX/2017 was deposited in laboratory plant systematics, Faculty 
of Biology, Universitas Gadjah Mada. Amphotericin B-Fungison 
(GibcoTM), Dulbecco’s modified Eagle’s medium (Gibco), dimethyl 
sulfoxide (DMSO) (Merck), Ceftriaxone, fetal bovine serum (Gibco), 
Formaldehyde 10% (Gibco), MTT (Sigma), medium Roswell park 
memorial Roswell park memorial Institute 1640 (Sigma), Penicillin-
Streptomycin (Gibco BRL), phosphate buffer saline (Gibco), Povidone-
iodine 10% (Gibco), and Trypsin EDTA 0,25% (Gibco) were used.
Extraction of T. diversifolia
About 1 kg of T. diversifolia leaves dried powder was macerated by 
ethanol (70%) (2 L). The mixture was stirred periodically for 24 h. The 
filtrate was separated by filtration (Buchner funnel), and maceration 
was repeated 3 times. The filtrates obtained were combined and 
evaporated in vacuo to dryness.
The 96 well plate culture preparation
Cell suspension was counted based on a number of group in the study 
in triplicate. Fibroblast cell culture harvested, washed, and made into 
suspension with concentration 2×105/mL medium. Each well on a plate 
then filled with 200 µL cell suspension and marked according to the 
research plan. Cells in 96 well plate were incubated in an incubator 
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CO2 5%, temperature 37°C for 24 h. Each work sample requires two 
plates for fibroblast proliferation and collagen accumulation, 1 plate for 
72 h and 1 plate for 120 incubation time, repeated up to 3 times.
Tested concentration preparation
About 5 mg of the ethanolic extract of T. diversifolia was diluted 
in 100 µL DMSO to obtain a stock solution (50.000 µg/mL). Then, 3 
series concentrations 5 µg/mL, 10 µg/mL, and 20 µg/mL of the extract 
were prepared.
Fibroblast migration assessment with scratch assay
Measurement of cell migration test by in vitro scratch assay method [8] 
and analyzed by the method used [9] wound creation on culture cell 
migration was done by scratching the well base using blue tip micro 
pipet. After the treatment was completed, all groups were incubated 
for 48 h, but every 24 h microscopic images were taken using an 
inverted microscope. The images obtained from each well plate sample 
were analyzed using Image J software to obtain the percentage of 
the scratch area. The percentage of cell migration is determined by 
100% - percentage of scratch area.
Measurement of TGF-β1 expression
The protocol of TGF-β1 measurement is performed according to the 
procedure issued by Koma Biotech.inc as a manufacturer of the human 
TGF-β1 measurement kit.
Measurement of VEGF expression
The protocol of VEGF measurement is performed according to the 
procedure issued by Koma Biotech.inc as a manufacturer of the human 
VEGF with Catalog No: K0331132.
Ethics approval of research
This research has received permission from the Ethics Committee 
Research Faculty of Medicine, University of Gadjah Mada based 
eligibility letter conduct, with the number KE/FK/426/EC.
RESULTS AND DISCUSSION
Fibroblast migration activity
The mean of keloid fibroblast migration activity is optimal decreased 
at 24 h with 10 μg/mL of T. diversifolia ethanolic extract treatment. 
The mean of keloid fibroblast migration activity was lower 
significantly compare those on other groups are shown in Fig. 1. The 
ethanolic extract of T. diversifolia treatment at a concentration of 
20 μg/mL, 10 μg/mL, and 5 μg/ml for 24 h on keloid fibroblast culture 
showed slower migration activity compare to those on keloid fibroblast 
culture without treatment (p<0.05). There was no difference on keloid 
fibroblast migration  activity among T. diversifolia ethanolic extract 
treated groups on 48 hours treatment (Fig. 2). These results suggest 
that the effects of ethanolic extract of T. diversifolia on the increase in 
the number of fibroblast cells of keloid occur inhibition or decrease 
in migratory activity in keloid cell fibroblasts. This indicates that cell 
migration activity at 48 h may close the wound in the scratch area.
The effect of the ethanolic extract of T. diversifolia inhibition on migratory 
activity of keloid fibroblasts is greater with increased concentration of 
ethanolic extract of T. diversifolia. This suggests that the administration 
of the ethanolic extract of T. diversifolia with concentration of 5 μg/mL 
does not provide the inhibitory effect. However, the difference between 
the concentration of the ethanolic extract of T. diversifolia and the keloid 
fibroblast control group was statistically significant (p<0.05).
Measurement of TGF-β1 expression
Ethanolic extract of T. diversifolia on the expression of TGF-β1 in keloid 
fibroblasts is shown in Fig. 3. This result shows that TGF-β1expression 
in keloid fibroblasts treatment with an ethanolic extract of T. 
diversifolia was lower compared to those on keloid fibroblast without 
treatment. The treatment by ethanolic extract of T. diversifolia with 
various concentrations of 5 µg/mL, 10 µg/mL, and 20 µg/mL in 
keloid fibroblasts has almost similar results shown in Fig. 3. It can be 
concluded that TGF-β1 expression was significantly lower in ethanolic 
extract of T. diversifolia group compared to those on keloid fibroblast 
without treatment (p<0.05).
Measurement of VEGF expression
Ethanolic extract of T. diversifolia on the expression of VEGF in keloid 
fibroblasts is shown in Fig. 4. This result shows that ethanolic extract 
of T. diversifolia various concentrations (20 µg/mL, 10 µg/mL, and 
5 µg/mL) in keloid fibroblasts showed different VEGF expression 
compare to those on keloid fibroblast control group (p<0.05). Ethanolic 
extract of T. diversifolia concentration of 20 µg/mL or which constitute 
the largest concentration has optimal results when compared to other 
concentrations of the ethanolic extract of T. diversifolia treatment 
group (p<0.05). The above data corroborate that the treatment with 
an ethanolic extract of T. diversifolia can inhibit cell proliferation 
Fig. 1: Effect of T. diversifolia extract on keloid fibroblasts 
migration activity (%) at 24 hours. Description: FK = Fibroblasts 
Keloid, T. diversifolia extract concentration 20μg/mL; 10μg/mL; 
and 5μg/mL
Fig. 2: Effect of T. diversifolia extract on keloid fibroblasts 
migration activity (%) at 48 hours. Description: FK = Fibroblasts 
Keloid, T. diversifolia extract concentration 20μg/mL; 10μg/mL; 
and 5μg/mL
Fig. 3: Effect of T. diversifolia extract on keloid fibroblasts 
TGF beta 1 expression. Description: FK = Fibroblasts Keloid, 
T. diversifolia extract concentration 20μg/mL; 10μg/mL; and 
5μg/mL
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through inhibition of keloid fibroblasts and decrease the synthesis of 
VEGF supernatant concentration groups with optimal concentrations 
decrease at 20 µg/mL compared to the control group keloid fibroblasts.
DISCUSSION
Cell migration is an important process to trigger the synthesis of new 
extracellular matrices and contributes to the wound healing process. 
On previous research [10], it is stated that fibroblasts taken from 
keloid tissue by cell culture will show an increase in migration activity. 
Treatment with ethanolic extract of T. diversifolia at a concentration 
of 20 µg/mL, 10 µg/mL, and 5 µg/mL for 24 h in this study showed a 
higher percentage of migration compared to keloid fibroblast untreated, 
but there was a significant difference at 48 h after treatment (p<0.05). 
This insignificant result is probably caused by decreased activity 
of mitochondria in fibroblast cells due to reactive oxygen species 
(ROS) increase. The rise of ROS may cause migration disorders due to 
changes in the function of tubulin proteins and actin, there is also a 
change in the growth factor activity of connective tissue growth factor 
in improving cell adhesion, Rac1 activity and also phosphorylation 
disturbance c-Jun N-terminal Kinase resulting in migration disorders 
in fibroblast cells [11,12]. Another study also showed similar keloid 
fibroblast migration between treated group and control group which 
might happen because the fibroblast cells are cultured many times which 
somehow can affect the cells ability to migrate. In addition, the method 
of scratching and washing of cells after a determined intervention time 
of 24 h and 48 h is done with caution because at the final washing before 
staining with hematoxylin Mayer many cells is detached. This may affect 
the migration measurement results using the Image J software.
Keloid formation may involve TGF-β expression by some neovascular 
endothelial cells by producing TGF-β autocrine. Gene expression of 
collagen Type I and IV also increased in keloid tissue. Increased collagen 
synthesis exceeds the amount of destruction and excess deposition 
in connective tissue. The collagen connective tissue is produced by 
fibroblast cells. Disturbed synthesis activities are mediated by changes 
in growth factor expression [13]. TGF-β especially TGF-β1 is the main 
cytokines involves in the development of organ fibrosis including keloid. 
Activation of TGF-β signaling in fibroblast cells causing phenotypic 
changes that may enhance the ability to proliferate and migrate or 
invasion. Increased TGF-β activity in fibroblast cells may also increase 
the ability to stimulate tissues re-modeling so as to further enhance 
the growth of keloid tissue. Thus, the inhibition of TGF-β pathway is a 
pathway or indicator of successful keloid therapy [14]. Treatment with 
ethanolic extract of T. diversifolia on keloid fibroblasts can lower TGF-β1 
expression significantly (p<0.05) compared with keloid fibroblasts 
control. This result which is consistency with the previous study [15] 
suggest that giving isolates from the butter flower leaf (Nerium indicum 
Mill.) can significantly lower the level of TGF-β1 synthesis compared 
to the keloid fibroblast control group (p<0.01) because TGF-β1 is 
the major pathway in keloid formation. In a study [16], it was found 
that the treatment of Xanthium stramarium and Psoralea corylifolia 
combined with Ultraviolet A1 radiation can inhibit TGF-β1 expression 
and collagen synthesis in keloid fibroblasts (p<0.05).
VEGF is a proangiogenesis cytokine that has an important role in normal 
as well as pathologic conditions of wound healing [17]. VEGF belongs 
to the group of growth factors have a major role in keloid incident, 
VEGF-induced angiogenesis directly through mitogenesis endothelial 
cells and indirectly by increasing the permeability of blood vessels and 
promotes deposition of extravascular fibrin matrix [18]. VEGF plays an 
important role in the formation of keloids by changing the extracellular 
matrix and increased endothelial cell proliferation [19]. VEGF is also 
important for vascular permeability that promotes neovascularization 
and cell growth [20,21]. Increased expression of VEGF in keloid is 
showed by the higher amount of VEGF expression in keloid fibroblast 
group compared with those on treated group. Increased expression of 
VEGF in keloid fibroblasts is caused by local hypoxia conditions that 
contributed to hypoxia-inducible factor (HIF-1), a VEGF expression 
stimulator [22]. Hypoxic conditions generally occur in the inflammatory 
phase of wound tissue due to disruption of the vascularization process 
around the wound so that oxygen delivery to other tissues is inhibited. 
This is exacerbated by the rapid influx of inflammatory cells in the 
wound tissue. The inflammatory cells play a role in the increase of 
granulation, re-epitelisasi, and proliferasi [23], cell response to 
hypoxic conditions is also called the HIF protein expression which is 
a transcription factor that plays an important role in maintaining the 
balance of oxygen. Increased of HIF-1α protein in keloid tissue result 
in increased expression of TGF-β, thrombospondin-1, plasminogen 
activator inhibitor-1, and VEGF which play a major role in driving 
the fibroblast proliferation [22]. Fibrosis in keloid tissue is caused by 
increased of exogenous and endogenous VEGF in keloid fibroblasts. 
Exogenous VEGF will increase the VEGF receptors, whereas 
endogenous VEGF will increase with increased transcription factor 
VEGF and insulin-like growth factor 1 in tissues fibroblasts keloid [19]. 
VEGF as a pro-angiogenic growth factor increase the keloid tissue 
angiogenesis that chronic inflammation occurs and persistent increase 
fibroblast proliferation. Ethanolic extract of T. diversifolia treatment 
of various concentrations (20; 10; and 5) µg/mL showed lower VEGF 
expression compared with those in keloid fibroblast control, with 
optimal decrease occurring at the concentration 20 μg/mL with 
VEGF expression value of 44.82 pg/mL when compared with keloid 
fibroblast group (p<0.05). The lowest VEGF expression is showed in the 
concentration of the ethanolic extract of T. diversifolia 20 µg/mL which 
is the highest treatment concentration. VEGF expression is optimal at 
that concentration. Another research results that VEGF is released in 
large amounts from degranulating platelets, and it is present in wound 
fluid, particularly early after injury. The expression of VEGF related 
antigen, a marker of vascular endothelial cell, a marker of proliferation, 
in the wounds showed that there was an increase in the number of new 
capillary sprouts in the three evidence-based practice (EBP) gel groups 
at varied extent, especially in 75% EBP gel groups, compared with that in 
control group on day 12 and day 16 after wounding [24]. Other research 
also concluded that ethyl acetate fraction of Andrographis paniculata 
and doxorubicin combination increase apoptosis and decrease VEGF 
protein expression of mice fibrosarcoma cells [25].
Based on the results of VEGF expression, ethanolic extract of 
T. diversifolia might inhibit the proliferation of keloid fibroblasts cells 
through the inhibition of the expression of VEGF and specifically inhibit 
the formation of a transcription factor of endogenous VEGF in keloid 
fibroblasts. VEGF is abundant in the dermis underlying keloids. In vitro 
studies have shown that VEGF is expressed at high levels in keloid 
fibroblasts derived from normal skin fibroblast [26].
CONCLUSION
Ethanolic extract of T. diversifolia can decrease migration activity 
on keloid fibroblast at 24 h in concentration 10 μg/mL. The TGF-β1 
Fig. 4: Effect of T. diversifolia extract on keloid fibroblasts 
VEGF A expression. Description: FK = Fibroblasts Keloid, T. 
diversifolia extract concentration 20μg/mL; 10μg/mL; and 
5μg/mL
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expression of Keloid fibroblast in 5 μg/mL ethanolic extract of 
T. diversifolia was lower compared to those on the control group. The 
expression of VEGF keloid fibroblast in all concentration ethanolic 
extract of T. diversifolia was lower compared to those on the control 
group.
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